(Q37065120)

18 August 2017

1 reference

title

Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema (English)

1 reference

18 August 2017

main subject

hereditary angioedema

1 reference

I Leonard Bernstein

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

Annals of Allergy, Asthma & Immunology

18 August 2017

published in

1 reference

18 August 2017

volume

100

1 reference

18 August 2017

issue

1 Suppl 2

1 reference

18 August 2017

page(s)

S2-6

1 reference

Hereditary periodic oedema

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

HEREDITARY ANGIO-NEUROTIC ŒDEMA

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

The inactivation of complement and its components by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

The influence of calcium ions on the inactivation of human complement and its components by plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Inhibition of immune hemolysis by diisopropyl fluorophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Elution of an esterase from antigen-antibody aggregates treated with human complement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

1 reference

7 January 2021

Observations on a pro-esterase associated with partially purified first component of human complement (C'1)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

The purification of activated Hageman factor (activated factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Vascular permeability factors (PF/Nat and PF/Dil)—their relationship to hageman factor and the kallikrein-kinin system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Assay and Properties of Serum Inhibitor of C'1-Esterase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Increased cutaneous response to diluted autologous serum in hereditarv ango-oedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Angioedema induced by a peptide derived from complement component C2.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Recurrent angioedema: familial and oestrogen-induced

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Hereditary angioedema with normal C1-inhibitor activity in women

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Acquired angioedema: observations on the mechanism of action of autoantibodies directed against C1 esterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Autoimmune C1 inhibitor deficiency: Report of eight patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

[Acquired C1 inhibitor deficiency associated with lymphoproliferative disorders: four cases]

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Acquired C1 esterase inhibitor deficiency or serendipity? The chance finding of a paraprotein after an apparently low C1 esterase inhibitor concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Acquired C1 Esterase Inhibitor Deficiency and Angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Detection of C1 inhibitor mutations in patients with hereditary angioedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Some properties of an esterase derived from preparations of the first component of complement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Plasma bradykinin in angio-oedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

The pathophysiology of hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960579-0

7 January 2021

10.1016/S1081-1206(10)60579-0

Identifiers

DOI

1 reference

18 August 2017

1 reference